Choline salicylate
Otinum is a medicine indicated for short-term use in inflammatory conditions of the external auditory canal characterized by pain, itching, and redness.
The medicine is also recommended for softening earwax before flushing the external auditory canal.
The active substance of Otinum ear drops is a salicylic acid derivative – choline salicylate.
Choline salicylate has analgesic and anti-inflammatory properties when used locally, which reduces pain and inflammation in the course of external otitis.
The glycerol contained in the medicine softens earwax in the ear, making it easier to remove.
After local administration to the ear, the medicine does not have a systemic effect.
Eardrum perforation may be indicated by: severe ear pain (gradually decreasing), ringing in the ears (which may indicate damage to deeper ear structures), hearing loss, dizziness, and/or discharge from the ear. The causes of eardrum damage (perforation) include: infections, injuries (e.g., after improper ear cleaning with earbuds), and medical procedures (e.g., improper ear flushing due to earwax).
Any ear pain is a reason to consult a doctor.
The medicine for the treatment of external otitis without consulting a doctor can be used for a short period, no longer than 3 days. If there is no improvement or worsening of symptoms despite using Otinum in the recommended doses for 3 days, you should contact your doctor.
If additional symptoms appear, indicating a developing disease process (e.g., fever, malaise, weakness, dizziness, discharge from the ear), you should contact your doctor.
In the event of recurrence of the disease, the use of Otinum should be decided by a doctor.
Otinum may mask the symptoms of other ear diseases and make their proper diagnosis difficult or delayed.
You should inform your doctor about the use of Otinum.
The medicine contains a preservative – chlorobutanol.
You must not use Otinum contrary to the indications listed in the leaflet or with a different route of administration (e.g., orally, on open wounds, especially in the ear canal or in the eyes).
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as medicines you plan to take. This also applies to over-the-counter medicines.
The medicine is used locally and does not have a systemic effect.
Concomitant use with non-steroidal anti-inflammatory drugs (e.g., aspirin, ibuprofen) may enhance the local effect.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before using this medicine.
The medicine does not affect the ability to drive vehicles or operate machinery.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If you have any doubts, you should consult a doctor or pharmacist.
Otinum is for local use in the ear only.
Otinum is intended for use in adults.
If you feel that the effect of Otinum is too strong or too weak, you should consult a doctor.
Patients with liver and/or kidney function disorders:
No dose adjustment is necessary.
It is impossible to overdose on the medicine by administering it to the ear.
Symptoms of overdose that may occur after accidental oral ingestion of the medicine include:
a state of disorientation, dizziness, excessive sweating, vomiting, ringing in the ears, and too rapid breathing (hyperventilation). In the event of taking very large doses of the medicine orally, there may be disorders of the central nervous system, including breathing and circulation disorders.
In the event of oral ingestion of the medicine, you should immediately consult a doctor.
If you miss a dose of the medicine at the scheduled time, you should take it as soon as possible.
However, if it is almost time for the next dose, you should skip the missed dose. Do not take a double dose to make up for the missed dose.
Like all medicines, Otinum can cause side effects, although not everybody gets them.
The frequency of the following side effects is unknown (cannot be estimated from the available data).
Local hypersensitivity reactions (redness and itching of the skin).
In patients with eardrum perforation during treatment, there may be hearing damage.
If you experience any side effects, including any possible side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the immediate packaging and the carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The packaging of the medicine is a 10 g polyethylene bottle with a dropper, in a carton. The packaging contains 10 g of the medicine.
SIA Meda Pharma
Mūkusalas 101
Riga LV-1004
Latvia
ICN Polfa Rzeszów S.A.
ul. Przemysłowa 2
35-959 Rzeszów
Poland
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Latvia, the country of export:96-0162
Parallel import authorization number:228/17
Date of leaflet approval: 12.05.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.